Clinical outcomes and prognostic factors of hepatic arterial infusion (HAI) chemotherapy combination regimens in 202 patients with advanced cancer metastatic to the liver: The phase I program M. D. Anderson Cancer Center experience.

Cancer Center ◽

Arterial Infusion ◽

Combination Regimens

A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-018-3680-y ◽

2018 ◽

Vol 82 (5) ◽

pp. 877-885 ◽

Cited By ~ 3

Author(s):

Elena Fountzilas ◽

Elangovan Krishnan ◽

Filip Janku ◽

Siqing Fu ◽

Daniel D. Karp ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Advanced Cancer ◽

Phase I Clinical Trial ◽

Liver Involvement ◽

Arterial Infusion ◽

Oral Capecitabine

A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without systemic bevacizumab, for patients with advanced cancer and liver involvement.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.2527 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 2527-2527

Author(s):

Elena Fountzilas ◽

Elangovan Krishnan ◽

Filip Janku ◽

Siqing Fu ◽

Daniel D. Karp ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Advanced Cancer ◽

Phase I Clinical Trial ◽

Liver Involvement ◽

Arterial Infusion ◽

Oral Capecitabine

Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1482-y ◽

2010 ◽

Vol 68 (1) ◽

pp. 247-253 ◽

Cited By ~ 16

Author(s):

Apostolia M. Tsimberidou ◽

Katherine Letourneau ◽

Siqing Fu ◽

David Hong ◽

Aung Naing ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Advanced Cancer ◽

Phase I Clinical Trial ◽

Liver Involvement ◽

Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1266-4 ◽

2010 ◽

Vol 66 (6) ◽

pp. 1087-1093 ◽

Cited By ~ 15

Author(s):

Apostolia M. Tsimberidou ◽

Stacy Moulder ◽

Siqing Fu ◽

Sijin Wen ◽

Aung Naing ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Advanced Cancer ◽

Liposomal Doxorubicin ◽

Phase I Clinical Trial ◽

Liver Involvement ◽

Abstract 2771: Clinical outcomes and prognostic factors in 83 patients with pancreatic cancer treated in phase I clinical trials at M.D. Anderson Cancer Center

10.1158/1538-7445.am10-2771 ◽

2010 ◽

Author(s):

Apostolia M. Tsimberidou ◽

Christos Vaklavas ◽

Sijin Wen ◽

David Hong ◽

Jennifer Wheler ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Trials ◽

Prognostic Factors ◽

Phase I ◽

Clinical Outcomes ◽

Cancer Center ◽

Phase I Clinical Trials

Prognostic factors for transarterial chemoembolization combined with sustained oxaliplatin-based hepatic arterial infusion chemotherapy of colorectal cancer liver metastasis

Chinese Journal of Cancer Research ◽

10.21147/j.issn.1000-9604.2017.01.05 ◽

2017 ◽

Vol 29 (1) ◽

pp. 36-44 ◽

Cited By ~ 3

Author(s):

Hangyu Zhang ◽

◽

Jianhai Guo ◽

Song Gao ◽

Pengjun Zhang ◽

...

Keyword(s):

Colorectal Cancer ◽

Prognostic Factors ◽

Liver Metastasis ◽

Transarterial Chemoembolization ◽

Hepatic Arterial Infusion Chemotherapy ◽

Arterial Infusion ◽

Arterial Infusion Chemotherapy ◽

Colorectal Cancer Liver Metastasis ◽

Infusion Chemotherapy

Hepatic arterial infusion (HAI) of fudr (F), leucovorin (L), adriamycin (A), and platinol (P),(FLAP) for hepatocellular carcinoma (HCC): Effect of hepatitis B and C viral markers on toxicity and patient survival Patt YZ, Yoffe B, Charnsangavej C, Smith R, Lawrence D, Chuang V, Roh M, Chase J, Fischer H, Levin B, U.T. M.D. Anderson Cancer Center, Houston, Texas

Hepatology ◽

10.1016/0270-9139(93)92295-b ◽

1993 ◽

Vol 18 (4) ◽

pp. A192

Keyword(s):

Hepatocellular Carcinoma ◽

Hepatitis B ◽

Patient Survival ◽

Cancer Center ◽

Phase I/II Study of Hepatic Arterial Infusion Chemotherapy With Gemcitabine in Patients With Unresectable Intrahepatic Cholangiocarcinoma (JIVROSG-0301)

American Journal of Clinical Oncology ◽

10.1097/coc.0b013e3181d2709a ◽

2011 ◽

Vol 34 (1) ◽

pp. 58-62 ◽

Cited By ~ 25

Author(s):

Yoshitaka Inaba ◽

Yasuaki Arai ◽

Hidekazu Yamaura ◽

Yozo Sato ◽

Mina Najima ◽

...

Keyword(s):

Phase I ◽

Intrahepatic Cholangiocarcinoma ◽

Hepatic Arterial Infusion Chemotherapy ◽

Arterial Infusion ◽

Arterial Infusion Chemotherapy ◽

Infusion Chemotherapy

Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma

Cancer Biotherapy & Radiopharmaceuticals ◽

10.1089/cbr.2017.2223 ◽

2017 ◽

Vol 32 (7) ◽

pp. 258-265 ◽

Cited By ~ 3

Author(s):

Benjamin Cahan ◽

Lucille Leong ◽

Lawrence Wagman ◽

David Yamauchi ◽

Stephen Shibata ◽

...

Keyword(s):

Liver Metastasis ◽

Colorectal Carcinoma ◽

Phase I ◽

Abstract 4410: Initiative for Molecular Profile and Advanced Cancer Therapy (IMPACT): A personalized medicine Phase I clinical trials program at MD Anderson Cancer Center

10.1158/1538-7445.am2011-4410 ◽

2011 ◽

Cited By ~ 1

Author(s):

Apostolia M. Tsimberidou ◽

David S. Hong ◽

Jennifer Wheler ◽

Siqing Fu ◽

Sarina Piha-Paul ◽

...

Keyword(s):

Clinical Trials ◽

Cancer Therapy ◽

Personalized Medicine ◽

Phase I ◽

Advanced Cancer ◽

Molecular Profile ◽

Cancer Center ◽

Phase I Clinical Trials ◽

Md Anderson